Elwakeel and Hazaa revealed in the patients with diabetes mellitus a significant improvement in clinical parameters plaque index (PI), GI, PD and CAL in the test group versus control group, and a highly significant reduction in the IL-1β level in the gingivocrevicular fluid (GCF) in the experimental group [11]. The gene discussed is IL1B; the disease is diabetes mellitus.